Dana Investment Advisors Inc. Boosts Holdings in Owens & Minor, Inc. (NYSE:OMI)

Dana Investment Advisors Inc. raised its position in shares of Owens & Minor, Inc. (NYSE:OMI) by 35.8% during the second quarter, HoldingsChannel reports. The fund owned 609,040 shares of the company’s stock after acquiring an additional 160,682 shares during the quarter. Dana Investment Advisors Inc.’s holdings in Owens & Minor were worth $8,222,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in OMI. Norges Bank purchased a new stake in Owens & Minor in the 4th quarter worth about $9,160,000. Franklin Resources Inc. lifted its stake in shares of Owens & Minor by 21.7% during the 4th quarter. Franklin Resources Inc. now owns 51,096 shares of the company’s stock worth $985,000 after acquiring an additional 9,121 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new position in Owens & Minor during the 4th quarter valued at $852,000. Gabelli Funds LLC grew its position in Owens & Minor by 14.9% in the 4th quarter. Gabelli Funds LLC now owns 135,000 shares of the company’s stock valued at $2,601,000 after acquiring an additional 17,500 shares during the last quarter. Finally, Quarry LP grew its position in Owens & Minor by 38.8% in the 4th quarter. Quarry LP now owns 2,573 shares of the company’s stock valued at $50,000 after acquiring an additional 719 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Owens & Minor Stock Performance

Shares of NYSE:OMI opened at $15.69 on Tuesday. The company has a quick ratio of 0.51, a current ratio of 1.09 and a debt-to-equity ratio of 2.17. The company has a market capitalization of $1.20 billion, a price-to-earnings ratio of -30.76, a price-to-earnings-growth ratio of 0.49 and a beta of 0.39. The firm has a 50 day moving average of $15.59 and a 200 day moving average of $18.40. Owens & Minor, Inc. has a 52 week low of $12.36 and a 52 week high of $28.35.

Owens & Minor (NYSE:OMI) last issued its quarterly earnings data on Friday, August 2nd. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.03. The firm had revenue of $2.67 billion for the quarter, compared to the consensus estimate of $2.65 billion. Owens & Minor had a negative net margin of 0.40% and a positive return on equity of 14.66%. The company’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.18 EPS. On average, sell-side analysts predict that Owens & Minor, Inc. will post 1.57 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. StockNews.com lowered shares of Owens & Minor from a “buy” rating to a “hold” rating in a research note on Monday, August 26th. Barclays lowered their price objective on shares of Owens & Minor from $23.00 to $18.00 and set an “equal weight” rating for the company in a research report on Monday, August 5th. Bank of America reduced their target price on shares of Owens & Minor from $18.00 to $16.00 and set an “underperform” rating on the stock in a research report on Tuesday, June 25th. Citigroup upgraded Owens & Minor from a “neutral” rating to a “buy” rating and lowered their price target for the company from $24.00 to $19.00 in a report on Friday, July 19th. Finally, Robert W. Baird reduced their price objective on Owens & Minor from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Tuesday, July 16th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $20.00.

About Owens & Minor

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.